Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91


Low target-INR anticoagulation is safe in selected aortic valve patients with the Medtronic Open Pivot mechanical prosthesis: long-term results of a propensity-matched comparison with standard anticoagulation.

Bové T, Van Belleghem Y, François K, Caes F, De Pauw M, Taeymans Y, Van Nooten GJ.

Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):862-868. doi: 10.1093/icvts/ivx028.


Proximal aortic stiffening in Turner patients may be present before dilation can be detected: a segmental functional MRI study.

Devos DG, De Groote K, Babin D, Demulier L, Taeymans Y, Westenberg JJ, Van Bortel L, Segers P, Achten E, De Schepper J, Rietzschel E.

J Cardiovasc Magn Reson. 2017 Feb 13;19(1):27. doi: 10.1186/s12968-017-0331-0.


Diagnostic accuracy of a novel method for detection of acute transmural myocardial ischemia based upon a self-applicable 3-lead configuration.

El Haddad M, Vervloet D, Taeymans Y, De Buyzere M, Bové T, Stroobandt R, Duytschaever M, Malmivuo J, Gheeraert P.

J Electrocardiol. 2016 Mar-Apr;49(2):192-201. doi: 10.1016/j.jelectrocard.2015.11.007. Epub 2015 Nov 23.


Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.


Novel X-ray imaging technology enables significant patient dose reduction in interventional cardiology while maintaining diagnostic image quality.

Eloot L, Thierens H, Taeymans Y, Drieghe B, De Pooter J, Van Peteghem S, Buytaert D, Gijs T, Lapere R, Bacher K.

Catheter Cardiovasc Interv. 2015 Nov;86(5):E205-12. doi: 10.1002/ccd.25913. Epub 2015 Mar 30.


Impact of gender difference in hospital outcomes following percutaneous coronary intervention. Results of the Belgian Working Group on Interventional Cardiology (BWGIC) registry.

Lempereur M, Magne J, Cornelis K, Hanet C, Taeymans Y, Vrolix M, Legrand V.

EuroIntervention. 2016 Jun 12;12(2):e216-23. doi: 10.4244/EIJY14M12_11.


Twenty-year single-center experience with the medtronic open pivot mechanical heart valve.

Van Nooten GJ, Bové T, Van Belleghem Y, François K, Caes F, Vandenplas G, De Pauw M, Taeymans Y.

Ann Thorac Surg. 2014 Apr;97(4):1306-13. doi: 10.1016/j.athoracsur.2013.11.035. Epub 2014 Feb 6.


Three-dimensional rotational X-ray acquisition technique is reducing patients' cancer risk in coronary angiography.

Eloot L, Bacher K, Steenbeke F, Drieghe B, Gheeraert P, Taeymans Y, Thierens H.

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E419-27. doi: 10.1002/ccd.24879. Epub 2013 Jul 1.


Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy.

Van Nooten GJ, Caes F, François K, Van Bellleghem Y, Bové T, Vandenplas G, Taeymans Y.

J Heart Valve Dis. 2012 Jan;21(1):88-98.


Ten years single-centre experience with intra-aortic balloon pump.

Vandenplas G, Bové T, Caes F, Van Belleghem Y, François K, De Somer F, Taeymans Y, Van Nooten G.

Acta Cardiol. 2011 Dec;66(6):707-13.


Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome.

Mack MJ, Banning AP, Serruys PW, Morice MC, Taeymans Y, Van Nooten G, Possati G, Crea F, Hood KL, Leadley K, Dawkins KD, Kappetein AP.

Ann Thorac Surg. 2011 Dec;92(6):2140-6. doi: 10.1016/j.athoracsur.2011.06.028. Epub 2011 Oct 2.


Active or passive bio-coating: does it matters in extracorporeal circulation?

Jacobs S, De Somer F, Vandenplas G, Van Belleghem Y, Taeymans Y, Van Nooten G.

Perfusion. 2011 Nov;26(6):496-502. doi: 10.1177/0267659111415146. Epub 2011 Jun 30.


A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial.

Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Allocco DJ, Dawkins KD; PLATINUM Trial Investigators.

J Am Coll Cardiol. 2011 Apr 19;57(16):1700-8. doi: 10.1016/j.jacc.2011.02.016. Epub 2011 Apr 4.


The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions.

Grube E, Chevalier B, Smits P, Džavík V, Patel TM, Mullasari AS, Wöhrle J, Stuteville M, Dorange C, Kaul U; SPIRIT V Investigators.

JACC Cardiovasc Interv. 2011 Feb;4(2):168-75. doi: 10.1016/j.jcin.2010.11.006.


Sutureless replacement of aortic valves with St Jude Medical mechanical valve prostheses and Nitinol attachment rings: feasibility in long-term (90-day) pig experiments.

Berreklouw E, Koene B, De Somer F, Bouchez S, Chiers K, Taeymans Y, Van Nooten GJ.

J Thorac Cardiovasc Surg. 2011 May;141(5):1231-7.e1. doi: 10.1016/j.jtcvs.2010.07.014. Epub 2010 Aug 21.


Hemodynamic effect of myocardial bridging.

Kersemans M, Van Heuverswyn F, De Pauw M, Gheeraert P, Taeymans Y, Drieghe B.

Circ Cardiovasc Interv. 2009 Aug;2(4):361-2. doi: 10.1161/CIRCINTERVENTIONS.109.855395. No abstract available.


A novel simulation strategy for stent insertion and deployment in curved coronary bifurcations: comparison of three drug-eluting stents.

Mortier P, Holzapfel GA, De Beule M, Van Loo D, Taeymans Y, Segers P, Verdonck P, Verhegghe B.

Ann Biomed Eng. 2010 Jan;38(1):88-99. doi: 10.1007/s10439-009-9836-5. Epub 2009 Nov 7.


Fifteen years' single-center experience with the ATS bileaflet valve.

Van Nooten GJ, Caes F, François K, Van Belleghem Y, Bové T, Vandenplas G, De Pauw M, Taeymans Y.

J Heart Valve Dis. 2009 Jul;18(4):444-52.


Drug-eluting stents: a study of international practice.

Austin D, Oldroyd KG, Holmes DR Jr, Rihal CS, Galbraith PD, Ghali WA, Legrand V, Taeymans Y, McConnachie A, Pell JP; APPROACH Investigators; Belgian Working Group on Invasive Cardiology; Mayo Clinic PCI Registry; Scottish Coronary Revascularisation Registry.

Am Heart J. 2009 Oct;158(4):576-84. doi: 10.1016/j.ahj.2009.07.033.


Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators.

N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18. Erratum in: N Engl J Med. 2013 Feb 7;368(6):584.

Supplemental Content

Loading ...
Support Center